RE: CEO - Article26 Sep 2024 12:59
RNS Reach - non-regulatory announcement
26 September 2024
Graft Polymer (UK) Plc
(the "Company")
Proactive Investors interview with Dennis Purcell
Graft Polymer (UK) PLC (LON: GPL), an innovative biotechnology company focused on co-developing therapeutics for mental health disorders, is pleased to note an interview on Proactive Investors with the Company's new Chairman, Dennis Purcell. Mr Purcell's appointment was announced earlier today.
The interview and accompanying article can be viewed at Proactive Investors: Graft Polymer UK appoints biotechnology industry leader Dennis Purcell as Chairman.